SCS
TPTX

Syquant Capital SAS’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Syquant Capital SAS’s Portfolio TPTX Stock Details TPTX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,500
Closed -$339K – 44
2022
Q2 		$339K Buy
+4,500
New +$339K 0.38% 21
2021
Q1 		– Sell
-5,000
Closed -$609K – 85
2020
Q4 		$609K Buy
+5,000
New +$609K 0.16% 66